Maxigen Biotech Inc. announced consolidated revenue results for the month and year to date ended May 2022. On a consolidated basis, revenues for May 2022 were
approximately TWD 52.411 million, an increase of 21.57% over the same period in 2021.

Revenues for January through May 2022 totaled TWD 215.144 million, an increase of 16.90% compared to the TWD 184.041 million for the same period in 2021.